Regulation of Sodium Iodide Symporter Gene Expression by Rac1/p38β Mitogen-activated Protein Kinase Signaling Pathway in MCF-7 Breast Cancer Cells

Sodium Iodide Symporter (NIS)-Mediated Radionuclide (131I, 188Re) Therapy of Liver Cancer After Transcriptionally Targeted Intratumoral in Vivo NIS Gene Delivery

(2011) Kathrin Klutz et al.   HUMAN GENE THERAPY

Telomerase-Driven Expression of the Sodium Iodide Symporter (NIS) forin VivoRadioiodide Treatment of Cancer: A New Broad-Spectrum NIS-Mediated Antitumor Approach

(2011) Garcilaso Riesco-Eizaguirre et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Sodium Iodide Symporter (NIS)-Mediated Radiovirotherapy for Pancreatic Cancer

(2010) Alan R. Penheiter et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle

(2010) Lenka Munoz et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer

(2010) M A Trujillo et al.   GENE THERAPY

Activation of the PI3 Kinase Pathway By Retinoic Acid Mediates Sodium/Iodide Symporter Induction and Iodide Transport in MCF-7 Breast Cancer Cells

(2009) E. Ohashi et al.   CANCER RESEARCH

Retinoic Acid Stimulation of the Sodium/Iodide Symporter in MCF-7 Breast Cancer Cells Is Meditated by the Insulin Growth Factor-I/Phosphatidylinositol 3-Kinase and p38 Mitogen-Activated Protein Kinase Signaling Pathways

(2008) Takahiko Kogai et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells

(2008) Takahiko Kogai et al.   JOURNAL OF ENDOCRINOLOGY